Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
TTP plc has entered into a technology advisory partnership with Cancer Research UK.
read more
Piramal has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform.
read more
Avacta Group announced collaborative work with the Centre for Virus Research at the University of Glasgow has shown that Affimer reagents which bind to the SARS-COV-2 virus spike protein prevent infection of human cells by a SARS-COV-2 model virus.
read more
Sirnaomics and PNI jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
read more
Lyell Immunopharma and PACT Pharma have announced a strategic partnership to jointly develop and test a next generation personalized anti-cancer T cell therapy against solid tumors.
read more
AI VIVO has announced its platform correctly identified dexamethasone as having high potential for the treatment of COVID-19 in April 2020.
read more
AGC Biologics produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech.
read more
ArcherDX is entering into a collaboration with Bristol Myers to utilize PCM assays to understand the potential benefits of MRD detection in cancer patients treated with immunotherapy.
read more
ISA announced plans to initiate a trial for the combination of ISA101b and Libtayo in oropharyngeal cancer.
read more
Ubiquigent announced the continuation of a collaboration with Bristol Myers Squibb.
read more
Quartesian has announced a partnership with Amyndas for their study evaluating the efficacy of AMY-101 in COVID-19 patients with ARDS.
read more
Panthera Biopartners has appointed Chris Dodd as Executive VP of Business Development – Oncology and CNS.
read more
Lonza and CELLINK have partnered to offer a 3D bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.
read more
ChargePoint Technology has announced the appointment of Kieran Coulton as Chairman.
read more